Select area to zoom
Created with Highcharts 11.1.0Apr '24Jul '24Oct '24Jan '251000.00857.20

Profile

Edit
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
URL https://www.lilly.com
Investor Relations URL https://investor.lilly.com/
HQ State/Province Indiana
Sector Health Care
Industry Pharmaceuticals
Next Earnings Release May. 01, 2025
Last Earnings Release Feb. 06, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Feb. 14, 2025

Profile

Edit
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
URL https://www.lilly.com
Investor Relations URL https://investor.lilly.com/
HQ State/Province Indiana
Sector Health Care
Industry Pharmaceuticals
Next Earnings Release May. 01, 2025
Last Earnings Release Feb. 06, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Feb. 14, 2025
Quickflows